ATTORNEY GENERAL ANNOUNCES EPI-PEN SETTLEMENT

Maryland Attorney General Anthony Brown says the state’s Antitrust Division has reached a four-point-five-million-dollar settlement with the company that sells the EpiPen.  The settlement with Mylan resolves concerns about anticompetitive conduct involving the cost, marketing, and availability of EpiPen products. Brown says for too long, Mylan has cornered the market on the lifesaving medication and driven up costs for Maryland families who had no choice but to pay. In addition to the financial payment, Mylan will increase the co-pay coupon for its authorized generic version of the EpiPen and increase access for vulnerable Marylanders.